/
Login
Analysis Scores
Damodaran ?
40/100
DCF hesaplanamadı (faaliyet kârı veya nakit akışı eksik)
Dalio Risk ?
54/100
Piotroski ?
4/9
Neutral
Previous period ROA data missing (C1 delta-ROA); Previous year data missing → margin comparison unavailable (C8)
Graham ?
QAR3.0
Ucuz
Active Metric?
2/4
Confidence?
51%
Valuation
Potential?
+70.8%
ROIC ?
-0.8%
Debt Cycle?
Geç Genişleme
Data
Data ?
4144
2010-02-22 → 2026-09-02
Risk Analysis (VaR)
Düşük
252 days
Annual Volatility ?
%17.4
VaR 95% ?
%1.89
daily max loss
VaR 99% ?
%2.63
daily max loss
CVaR 95% ?
%2.40
expected loss (tail)
Max Drawdown ?
%26.2
15.02.2026 → 25.08.2026
Skewness ?
0.89
Parametrik%1.89
Historik%1.62
Cornish-Fisher%1.43
Return Distribution
Fundamental & Technical Analysis
TRAMA-99 Trend — Near TRAMA
Price (0.80), TRAMA-99 line (0.83) at close levels (%-3.5). Important decision zone — breakout direction will determine the trend.
Price:: 0.802
TRAMA: 0.8307
Difference: %-3.5
Profitability
Net Profit Margin
%17.5
Net profit margin %17.5 — at healthy level. Compared to previous quarter +6.8 point increase.
EBITDA Margin
%39.0
EBITDA margin %39.0 — operationally very efficient.
Gross Profit Margin
%28.5
Gross profit per revenue %28.5. Evaluate relative to sector.
Free Cash Flow Margin (TTM)
%-11.4
TTM Free Cash Flow is %-11.4'i. Negative FCF — company consuming cash.
Valuation
P/E Ratio
6.6x
Sector: 10.7x
F/K 6.6x — sector median's (10.7x) %38 below. Attractive for value investing.
P/B Ratio
0.25x
Sector: 1.06x
PD/DD 0.25x — sector median's (1.06x) çok below. Defter değerine göre undervalued.
EV/EBITDA
9.9x
Sector: 9.8x
EV/EBITDA 9.9x — sector median's (9.8x) %2 above. EBITDA’ya göre pahalı.
Indebtedness
Current Ratio
2.05x
Current ratio 2.05x — current assets are 2x short-term liabilities. Very healthy liquidity.
Net Debt / EBITDA
7.3x
Net Borç/EBITDA 7.3x — excessive leverage. Fragile debt profile.
Debt / Equity
0.42x
Low leverage — majority of assets financed by equity.
Interest Coverage
2.6x
Interest coverage 2.6x — limited buffer. May tighten if profitability drops.
Growth
Revenue Growth (YoY)
%+19.5
Revenue YoY %19.5 grew — healthy growth rate.
Net Profit Growth (YoY)
%+2.6
Net profit YoY %2.6 increased — positive but moderate growth.
Score Explanations
Lothien Robustness
64/100
Good robustness (64/100). The company shows a generally balanced financial profile; some areas have room for improvement.
Strong
Potential
+70.8%
Plus %70.8 expected value (1.37) vs current price comparison. 2/4 valuation models give 'BUY' signal. Model confidence %51.
Components: P/B target: 2.41 | EV/EBITDA target: 0.79
Damodaran Valuation
40/100
Low Damodaran score (40/100). ROIC (%-0.8) below cost of capital. DCF analysis does not support current price. Minusk/sorunlu: DCF hesaplanamadı (faaliyet kârı veya nakit akışı eksik).
Weak
Dalio Risk Analysis
54/100
Moderate debt risk (54/100). Interest coverage ratio 2.6x — acceptable. Borç/EBITDA 7.3x — high debt burden.
Leverage: 66/100 | Debt Service: 79/100 | Quality: 61/100
ROIC – Sermaye Getirisi
%-0.8
ROIC (%-0.8) cost of capitaln (7.6%) below → destroying value.
WACC: %7.6
Debt Cycle Phase
Geç Genişleme
Debt cycle phase: Geç Genişleme
Piotroski F-Score
4/9
Weak Piotroski (4/9). Many balance sheet quality criteria not met. Note: Previous period ROA data missing (C1 delta-ROA); Previous year data missing → margin comparison unavailable (C8)
Neutral
Graham Intrinsic Value
QAR3.0
Graham intrinsic value: QAR3.0. Ucuz
Cheap
⚖️ Sector Comparison
P/E Ratio
6.6x
vs 10.7x
Sector mediannın %38 below — cheap
P/B Ratio
0.25x
vs 1.06x
Compared to sector %77 cheaper (by book value)
EV/EBITDA
9.9x
vs 9.8x
Compared to sector %2 higher EV/EBITDA
ROIC vs WACC
%-0.8
vs %7.6 WACC
ROIC 8.5 baz puan cost of capitaln altında
Charts
Indicators
BB deviation
?
RSI thresholds
?
UDCD — Participation Finance Compliance
Loading…
The Lothien health scores and analyses on this page are for informational purposes only. They do not constitute investment advice. Please consult a licensed investment advisor before making investment decisions.